Disclosure Of First-Time Adoption [Text Block]

Sopharma AD - Filing #6175083

Concept As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
68 628 BGN
716 634 BGN
35 263 BGN
12 488 BGN
11 976 BGN
509 869 BGN
52 203 BGN
134 798 BGN
4 745 BGN
704 658 BGN
560,000 BGN
50 284 BGN
66 201 BGN
36 788 BGN
444 634 BGN
658 868 BGN
1 644 BGN
12 512 BGN
646 975 BGN
11 893 BGN
682,000 BGN
134 798 BGN
13 326 BGN
63 335 BGN
28 425 BGN
360 770 BGN
553 269 BGN
134 798 BGN
2 685 BGN
33 656 BGN
566 595 BGN
2 282 BGN
Comprehensive income
70 465 BGN
72 476 BGN
5 355 BGN
892,000 BGN
1 047 BGN
65 110 BGN
5 427 BGN
1 728 BGN
9 485 BGN
101 970 BGN
3 367 BGN
355,000 BGN
103 698 BGN
89 473 BGN
Profit (loss)
76 333 BGN
71 121 BGN
5 212 BGN
71 121 BGN
2 207 BGN
89 496 BGN
91 703 BGN
89 496 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.